Retina

Delay to first anti-VEGF injection leads to worse visual outcomes

A delay of >3 months from the time of diagnosis to treatment with first intravitreal aflibercept injection (IAI) was associated with lower visual gains in patients with macular edema due to central/branch retinal vein occlusion (MEfCRVO/MEfBRVO) compared to first treatment <1 month from diagnosis, according to a poster presented at...